Eichinger, Paul
Alberts, Esther
Delbridge, Claire
Trebeschi, Stefano https://orcid.org/0000-0002-5714-289X
Valentinitsch, Alexander
Bette, Stefanie
Huber, Thomas
Gempt, Jens
Meyer, Bernhard
Schlegel, Juergen
Zimmer, Claus
Kirschke, Jan S. https://orcid.org/0000-0002-7557-0003
Menze, Bjoern H.
Wiestler, Benedikt
Article History
Received: 20 April 2017
Accepted: 27 September 2017
First Online: 17 October 2017
Competing Interests
: C.Z. has served on scientific advisory boards for Philips and Bayer Schering; serves as co-editor on the Advisory Board of Clinical Neuroradiology; has received speaker honoraria from Bayer-Schering and Philips and has received research support and investigator fees for clinical studies from Biogen Idec, Quintiles, M.S.D. Sharp & Dome, Boehringer Ingelheim, Inventive Health Clinical U.K. Ltd., Advance Cor, Brainsgate, Pfizer, BayerSchering, Novartis, Roche, Servier, Penumbra, W.C.T. GmbH, Syngis, S.S.S. Internartional Clinical Research, P.P.D. Germany GmbH, Worldwide Clinical Trials Ltd., Phenox, Covidien, Actelion, Medivation, Medtronic, Harrison Clinical Research, Concentric, Penumbra, Pharmtrace, Reverse Medical Corp., Premier Research Germany Ltd., Surpass Medical Ltd. and GlaxoSmithKline. S.B., T.H., J.G. and B.M. work as consultants for Brainlab (Brainlab A.G., Feldkirchen). J.S.K. has received speaker honoraria from Philips. All listed potential conflicts of interest are unrelated to this study.